Will Genpact (G) Beat Estimates Again in Its Next Earnings Report?

18.10.24 18:10 Uhr

Werte in diesem Artikel
Aktien

41,58 EUR -0,41 EUR -0,98%

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Genpact (G). This company, which is in the Zacks Outsourcing industry, shows potential for another earnings beat.When looking at the last two reports, this business process management services provider has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 7.01%, on average, in the last two quarters.For the last reported quarter, Genpact came out with earnings of $0.79 per share versus the Zacks Consensus Estimate of $0.73 per share, representing a surprise of 8.22%. For the previous quarter, the company was expected to post earnings of $0.69 per share and it actually produced earnings of $0.73 per share, delivering a surprise of 5.80%.Thanks in part to this history, there has been a favorable change in earnings estimates for Genpact lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.Genpact has an Earnings ESP of +1.04% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on November 7, 2024.Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Genpact Limited (G): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Genpact

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Genpact

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Genpact LtdShs

Analysen zu Genpact LtdShs

DatumRatingAnalyst
08.08.2019Genpact BuyNeedham & Company, LLC
14.06.2019Genpact BuyNeedham & Company, LLC
04.08.2017Genpact Market PerformBMO Capital Markets
04.08.2017Genpact NeutralWedbush Morgan Securities Inc.
11.04.2016Genpact UnderperformRBC Capital Markets
DatumRatingAnalyst
08.08.2019Genpact BuyNeedham & Company, LLC
14.06.2019Genpact BuyNeedham & Company, LLC
04.08.2017Genpact Market PerformBMO Capital Markets
29.08.2011Genpact outperformOppenheimer & Co. Inc.
19.05.2011Genpact outperformOppenheimer & Co. Inc.
DatumRatingAnalyst
04.08.2017Genpact NeutralWedbush Morgan Securities Inc.
02.03.2015Genpact HoldDeutsche Bank AG
05.02.2015Genpact HoldDeutsche Bank AG
DatumRatingAnalyst
11.04.2016Genpact UnderperformRBC Capital Markets
30.07.2010Genpact sellKaufman Bros., LP

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Genpact LtdShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"